Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Paramyxovirus SV5 and multiple sclerosis.

B Vandvik1, E Norrby

  • 1Institute of Immunology and Rheumatology, Rikshospitalet National Hospital, University of Oslo School of Medicine, Norway.

Nature
|April 27, 1989
PubMed
Summary

This study investigated the link between Simian Virus 5 (SV5) and multiple sclerosis (MS). Researchers found no strong evidence that SV5 antibodies are a major cause of the intrathecal immune response observed in MS patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Monoclonal antibodies against morbilliviruses.

Revue scientifique et technique (International Office of Epizootics)·2020
Same author

Prions and protein-folding diseases.

Journal of internal medicine·2011
Same author

MS and clinically isolated syndromes: shared specificity but diverging clonal patterns of virus-specific IgG antibodies produced in vivo and by CSF B cells in vitro.

European journal of neurology·2009
Same author

GAD65 IgG autoantibodies in stiff person syndrome: clonality, avidity and persistence.

European journal of neurology·2008
Same author

T cells from multiple sclerosis patients recognize immunoglobulin G from cerebrospinal fluid.

Multiple sclerosis (Houndmills, Basingstoke, England)·2003
Same author

Diagnostic validity of somatosensory evoked potentials in subgroups of patients with sciatica.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2002

Area of Science:

  • Neuroimmunology
  • Virology
  • Central Nervous System Disorders

Background:

  • Multiple sclerosis (MS) is characterized by an immune response within the central nervous system (CNS).
  • Oligoclonal IgG bands in cerebrospinal fluid (CSF) are a hallmark of this intrathecal immune response in MS patients.
  • Previous research suggested Simian Virus 5 (SV5) might be involved in MS pathogenesis.

Purpose of the Study:

  • To investigate the potential role of SV5 as a major intrathecal immunogen in multiple sclerosis.
  • To determine if antibodies reacting with SV5 are associated with oligoclonal IgG bands in MS patients' CSF.

Main Methods:

  • Studied thirty patients diagnosed with multiple sclerosis.
  • Analyzed cerebrospinal fluid (CSF) for intrathecal synthesis of IgG antibodies.
  • Tested for antibodies reacting with SV5 and other paramyxoviruses.
  • Assessed the association of identified antibodies with oligoclonal IgG bands in CSF.

Main Results:

  • Intrathecal synthesis of IgG antibodies reacting with SV5 was found in seven out of thirty MS patients.
  • These SV5-reactive antibodies were not associated with the presence of oligoclonal IgG bands in CSF.
  • The identified antibodies could be explained as cross-reacting with other known human paramyxoviruses.

Conclusions:

  • The study could not confirm SV5 as a major intrathecal immunogen in multiple sclerosis.
  • The findings suggest that observed SV5-reactive antibodies in MS patients may be due to cross-reactivity with other viruses.
  • The link between SV5 and the characteristic intrathecal immune response in MS remains unproven by this study.

Related Experiment Videos